MolNFT v1 · #63570 · protein
Structure-based drug design of novel aurora kinase a inhibitors: structure basis for potency and specificity
3FDN: “Structure-based drug design of novel aurora kinase a inhibitors: structure basis for potency and specificity”. X-ray diffraction. MolNFT v1 #63570 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3FDN
- Type
- protein
- Length
- 261 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- O14965
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 261 | — | O14965 |
Compared structures
- 3FDN · Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for… · the same entry in another collection · chain A against A, TM-score 1.00
- O14965 · AlphaFold monomer V2.0 prediction for aurora kinase a (O14965) · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O14965
- Elsewhere: RCSB PDB 3FDN · PDBe 3FDN · UniProt O14965
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.